Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net income	$ 1,802	$ 1,543
Increase (decrease) in cash from operating assets and liabilities:
Accounts receivable	(90)	238
Inventories and other assets	77	(214)
Accounts payable and accrued expenses	(517)	(1,066)
Depreciation and amortization	795	756
Income taxes	444	372
Losses (gains) on sales of facilities	(201)	15
Amortization of debt issuance costs and discounts	9	9
Share-based compensation	87	77
Other	63	73
Net cash provided by operating activities	2,469	1,803
Cash flows from investing activities:
Purchase of property and equipment	(1,118)	(1,197)
Acquisition of hospitals and health care entities	(96)	(115)
Sales of hospitals and health care entities	310	165
Change in investments	2	(13)
Other	(1)	9
Net cash used in investing activities	(903)	(1,151)
Cash flows from financing activities:
Issuance of long-term debt	4,483	0
Net change in revolving credit facilities	(1,880)	1,240
Repayment of long-term debt	(2,066)	(550)
Distributions to noncontrolling interests	(152)	(187)
Payment of debt issuance costs	(40)	(3)
Payment of dividends	(185)	(175)
Repurchase of common stock	(1,180)	(846)
Other	(196)	(204)
Net cash used in financing activities	(1,216)	(725)
Effect of exchange rate changes on cash and cash equivalents	(1)	7
Change in cash and cash equivalents	349	(66)
Cash and cash equivalents at beginning of period	935	908
Cash and cash equivalents at end of period	1,284	842
Interest payments	538	574
Income tax payments, net	$ 1	$ 7